A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy.
Wang Y, Mei Y, Ao Z, Chen Y, Jiang Y, Chen X, Qi R, Fu B, Tang J, Fang M, You M, Zhang T, Yuan Q, Luo W, Xia N.
Wang Y, et al. Among authors: xia n.
Antiviral Res. 2022 Mar;199:105265. doi: 10.1016/j.antiviral.2022.105265. Epub 2022 Feb 17.
Antiviral Res. 2022.
PMID: 35183645
Free article.